Michal M Rączy (Michal R Raczy, Michal M Raczy)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 7

Top Topics

Infectious Diseases

Top Venues

Science advances

Scientific reports

Science translational medicine

bioRxiv : the preprint server for biology

This page only lists publications with an associated author ORCID identifier.

Publications

Dheeraj Soni, Francesco Borriello, David A Scott, Frederic Feru, Maria De Leon, Spencer E Brightman, Wing Ki Cheng, Gandolina Melhem, Jennifer A Smith, Juan C Ramirez, Soumik Barman, Michael D Cameron, Aisling Kelly, Kristina Walker, Etsuro Nanishi, Simon Daniel van Haren, Tony Phan, Yizhi Qi, Robert Kinsey, Michal M Rączy, Al Ozonoff, Matthew A Pettengill, Jeffrey A Hubbell, Christopher B Fox, David J Dowling, Ofer Levy
From hit to vial: Precision discovery and development of an imidazopyrimidine TLR7/8 agonist adjuvant formulation. Science advances 10 (27) (2024)
Michael J V White, Melis Ozkan, Jorge Emiliano Gomez-Medellin, Michal M Rączy, Kyle M Koss, Solanki Aniruddhsingh, Zheng Jenny Zhang, Aaron T Alpar, Bilal A Naved, Jason A Wertheim, Jeffrey A Hubbell
Blocking antibodies against integrin-α3, -αM, and -αMβ2 de-differentiate myofibroblasts, and improve lung fibrosis and kidney fibrosis. Scientific reports 14 (1) (2024)
Dheeraj Soni, Francesco Borriello, David A Scott, Frederic Feru, Maria De Leon, Spencer E Brightman, Wing Ki Cheng, Gandolina Melhem, Jennifer A Smith, Juan C Ramirez, Soumik Barman, Michael D Cameron, Aisling Kelly, Kristina Walker, Etsuro Nanishi, Simon Daniel van Haren, Tony Phan, Yizhi Qi, Robert Kinsey, Michal M Rączy, Al Ozonoff, Matthew A Pettengill, Jeffrey A Hubbell, Christopher B Fox, David J Dowling, Ofer Levy
From hit to vial: Precision discovery and development of an imidazopyrimidine TLR7/8 agonist adjuvant formulation. Science advances 10 (27) (2024)
Dheeraj Soni, Francesco Borriello, David A Scott, Frederic Feru, Maria De Leon, Spencer E Brightman, Wing Ki Cheng, Gandolina Melhem, Jennifer A Smith, Juan C Ramirez, Soumik Barman, Michael D Cameron, Aisling Kelly, Kristina Walker, Etsuro Nanishi, Simon Daniel van Haren, Tony Phan, Yizhi Qi, Robert Kinsey, Michal M Rączy, Al Ozonoff, Matthew A Pettengill, Jeffrey A Hubbell, Christopher B Fox, David J Dowling, Ofer Levy
From hit to vial: Precision discovery and development of an imidazopyrimidine TLR7/8 agonist adjuvant formulation. Science advances 10 (27) (2024)
Rachel P Wallace, Kirsten C Refvik, Jennifer T Antane, Kym Br ºnggel, Andrew C Tremain, Michal M Rączy, Aaron T Alpar, Mindy Nguyen, Solanki Aniruddhsingh, Anna J Slezak, Elyse A Watkins, Abigail L Lauterbach, Shijie Cao, D Scott Wilson, Jeffrey A Hubbell
Synthetically mannosylated antigens induce antigen-specific humoral tolerance and reduce anti-drug antibody responses to immunogenic biologics. bioRxiv : the preprint server for biology (2023)
Jun Ishihara, Ako Ishihara, Koichi Sasaki, Steve Seung-Young Lee, John-Michael Williford, Mariko Yasui, Hiroyuki Abe, Lambert Potin, Peyman Hosseinchi, Kazuto Fukunaga, Michal M Rączy, Laura T Gray, Aslan Mansurov, Kiyomitsu Katsumata, Masashi Fukayama, Stephen J Kron, Melody A Swartz, Jeffrey A Hubbell
Targeted antibody and cytokine cancer immunotherapies through collagen affinity. Science translational medicine 11 (487) (2020)
Kiyomitsu Katsumata, Jun Ishihara, Aslan Mansurov, Ako Ishihara, Michal M Rączy, Eiji Yuba, Jeffrey A Hubbell
Targeting inflammatory sites through collagen affinity enhances the therapeutic efficacy of anti-inflammatory antibodies. Science advances 5 (11) (2019)